Table 1.

The expression of CD14⁺CD16⁺ monocytes in AL patients and normal controls (x̅ ± s)

	AL patients in period of onset	AL patients in remission	Normal controls
N	68	68	50
The proportion of CD14+CD16+ monocytes	18.56 ± 6.89	7.73 ± 3.48	6.29 ± 1.91
The proportion of non-classical monocytes	6.34 ± 3.82	2.60 ± 1.92	2.75 ± 1.09
The proportion of intermediate monocytes	10.24 ± 5.49	4.51 ± 2.47	3.00 ± 1.37